Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Droperidol Efficacy and Clinical Positioning in Migraine Treatment

Efficacy Compared to Other Migraine Treatments

  • Subcutaneous sumatriptan 6mg provides 59% complete pain relief by 2 hours, while droperidol achieves 81-87% headache response rates at 2 hours across multiple doses, according to the American Family Physician guideline rated prochlorperazine with an efficacy score of 4 versus metoclopramide's score of 2 1
  • The American College of Physicians explicitly recommends against using opioids for acute episodic migraine, and droperidol is superior to meperidine for migraine treatment 2

Clinical Positioning in Treatment Algorithm

  • The recommended treatment hierarchy is: first-line NSAIDs or acetaminophen 1, second-line triptan + NSAID combination 3, third-line CGRP antagonists or ergot alkaloids 2, and fourth-line lasmiditan 2
  • Droperidol functions as a highly effective rescue therapy when these guideline-recommended treatments fail, particularly in emergency department or urgent care settings [2] [3]

Optimal Dosing Strategy

  • The minimum effective dose is 2.5 mg given IM or IV, with efficacy plateaus above 2.75 mg while side effects increase, starting with 2.5 mg is recommended 1